NLARx Newsletter Header
NLARx News
 October 22, 2008
In This Issue
In the States
Conferences
Outrage of the Week
Prices & Access
Conflicts of Interest
Advertising & Marketing
Fraud & Abuse
Safety and Clinical Trials
Campaign 2008
Pharma Watch
PBM Watch
Medicare
Medicaid
Patents & Generics
Privacy
Reimportation
Quick Links
Join Our Mailing List
In the States
TEXAS: Texas, 33 States Reach Landmark $62 Million Settlement With Eli Lilly & Co. More
NEW JERSEY: Informed Consent Bill Stymied By Senator More

MASSACHUSETTS: Bay State Ranked Worst for Pharma Sales and Marketing More
ILLINOIS: Medicaid Program to Cover Genetic Test for Breast Cancer More
STATES RIGHTS: Supreme Court To Hear Case on Whether FDA Approval of Rx Protects Manufacturers From Liability Lawsuits Filed in State Courts More
Upcoming Conferences
2008 International Symposium on Pharmaceuticals in the Home and Environment: Catalysts for Change More
Outrage of the Week
US Court Upholds Bayer, Barr Deal to Delay Generic Cipro More

Prices and Access to Healthcare
Some U.S. Residents Cut Back on Prescription Drugs To Save Money More
Layoffs Driving More People to Consider Prescription-Drug Assistance Programs Normally Aimed at the Poorest Americans More

One in Eight Advanced Cancer Patients Delays, Avoids Needed Treatment Due to Cost  More
Growing Number of U.S. Residents Delay Medical Care as Economy Worsens More
U.S. Infant Mortality Declines by 2% in 2006 But Rates Remain Higher Than Other Nations More
Conflicts of Interest
Houses Investigating FDA-EthicAd Link More

NIH Suspends $9.3 Million Grant to Emory University Amid Questions Over Pharma Payments More
NIH Requires Emory To Disclose All Conflicts More
GAO Says Broader FDA Recruitment Of Advisers May Find Ones Without Conflicts More
Sens. Grassley, Kohl Ask for Disclosure of Financial Contributions From Medical Device Makers More
Excerpt from Interview with Sen. Grassley More
Wisconsin Medical Society Bans Pharma Gifts More
Advertising and Marketing
New Neurontin Reports Paint Picture of Data Spin More
Merck's Goal: "One Less" Gardasil Marketing Problem More
Defusing a Time Bomb More
Eli Lilly to Pay States $1.4 Billion in Zyprexa Marketing Case More
House Panel Questions Ties Between Company Designing Drug Ad Web Site, Drug Marketing Firm More
Nexium, Actos, Ambien Sites Tops for Web Traffic More
Congress Probes Bayer Ads & FDA Web Site More
Drug Companies Reduced Spending on Advertisements in First Six Months of 2008 More
Glaxo Will Pay Health Plans $40 Million, End Claims Related to Paxil Use by Minors More
eMarketers Make a Comeback Inside Pharma More
Fraud and Abuse
Pfizer to Pay $894 Million to Settle Claims Over Bextra and Celebrex More
Suit Alleges Pfizer Spun Unfavorable Drug Studies for Neurontin More
Amgen Sales Rep Can Pursue Wrongful Firing Suit More
The 'King of Viagra' Is Jailed For Fraud More
Experts Conclude Pfizer Manipulated Studies More
Court Certifies Two National Classes Against AstraZeneca, Bristol-Myers Squibb More
Man pleads guilty to Medicare Fraud in LA More

Safety and Clinical Trials
J&J Paid $68 Million to Settle Birth-Control Cases More
Bush Rule Changes Could Block Product-Safety Suits More
Prescription Drugs, Products Liability, and Preemption of Tort Litigation More
FDA Visits to Foreign Drug Makers Would Take 13 Years More
FDA Is Faulted for Oversight of Foreign Drugs More
FTC Shuts Down Spam Network More
FDA Issues Warnings About Surgical Meshes More
Biologics Have High Rate Of Safety Risks: Study More

FDA Pushed Industry's 'Voluntary' Ban on Cold Meds for Young Kids More
Long-Term Study Confirms Vioxx Heart Risks More
FDA & Pharma: What's A Deadline Among Friends? More
Merck Expands Study For Failed Cholesterol Drug More
Truth In Numbers: How Statistics Can Mislead More
Pending Law Will Regulate Online Prescription-Drug Sales More

Campaign 2008
Obama Says McCain Would Make 'Drastic Cuts' in Medicare; McCain Campaign Disputes Charge More
Pharma Donations About Even to Democrats, Republicans, After Years of Favoring GOP More
Results are In: Pharma Favors Obama More

Pharma Watch
Analyst: King Pharma Chief Grossly Overpaid More
Merck To Cut 7,200 Jobs, Close 3 Research Labs More
Pharma Not as Fazed by Wall Street Turmoil More
Strong Dollar May Hurt Pharma Earnings More
Big Pharma Embraces Contentious Cancer Biz More
HPV Vaccine Gaining Acceptance More
US Recession May Hurt AIDS Vaccine Research More
Drug Companies Plan To Invest in HIV/AIDS Drug Development, Improve Access, U.N. Secretary-General Says More
PBM Watch
$10M Contest To Develop Proposals To Improve Health Quality, Reduce Costs More
Pharmacies Seek Rx for Low Reimbursements More
Nearly 1 in 6 Online Health Insurance Shoppers Deemed 'Uninsurable' by Industry More
CVS Caremark Shares Rise Amid Analyst Praise More
Big Chains Give Small Drugstores Headaches More

Medicare 
Rep. Waxman Questions CMS on Premium Increases for Drug Plans More
'Doughnut Hole' Prompts Many Beneficiaries To End Treatment With Medications More
Medicare Releases Online Tools More

Medicaid
Study Examines Florida Medicaid Pilot Program More
Physicians Brace for Medicaid Payment Cuts in 2009 Amid Weak Economy More
Medicaid Spending Projected to Rise Much Faster Than the Economy More
Medicaid Costs Projected To Grow by 7.9% Annually, According to CMS Report More
CMS: Medicaid Spending to Hit $674 Billion by 2017 More

Patents and Generics
Patient Safety, Data Exclusivity Key Issues For Generic Biologics Pathway, BIO Says More
Rx Benefit Managers Say Carve-Outs To Prevent Generic Use Would Boost Costs More
Feds Drop Legal Action Against Ranbaxy More

Pfizer Goes Generic More
Novartis Shows Generics Can Be Tricky Business for Big Pharma More

Privacy
Aetna and Microsoft Will Allow Patients to Transfer Medical Records to Health-Record Web site HealthVault More
Trade and Reimportation
Proposed Controls Threaten EU Drug Trade More